Coronavirus Disease (COVID)-19: World Health Organization Definitions and Coding to Support the Allergy Community and Health Professionals

Tanno, Luciana Kase; Casale, Thomas B.; Demoly, Pascal

doi:10.1016/j.jaip.2020.05.002

Cited by 21 publications

(13 citation statements)

References 9 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These actions generally follow the recommendations issued by WHO, which aims are to: (i) interrupt human-to-human transmission including reducing secondary infections, preventing transmission amplification events, and preventing further international spread; (ii) identify, isolate, and care for patients early; identify and reduce transmission from the animal source; (iii) address crucial unknowns regarding clinical severity, diagnosis, magnitude of transmission and infection, treatment options; (iv) communicate critical risk and accurate information to all communities; (v) minimize the burden of the conditions related to the pandemic through multisectoral partnership. 6,7 A combination of public health measures is crucial to prevent further spread at the international level, such as rapid identification, diagnosis and management of cases, identification and follow up of the contacts, infection prevention and control in health care settings, implementation of health measures for travellers, awareness raising in the population and risk communication. Diagnostic testing for COVID-19 is critical to track the SARS-CoV-2, inform case management, understand its epidemiology and trends, and suppress transmission.…”

Section: Dynamic Trends Of the Covid-19 Pandemicmentioning

confidence: 99%

“…In fact, the concern is higher in lowand middle-income countries, where health resources are limited and reduced means of testing hampers the diagnosis. 7 Allergy & COVID-19: evidence-based data are missing As in other fields, knowing what is effective requires scientific evidence. Yet, the evidence base that informs the actions of public health agencies and institutions in preparing for and responding to emergencies is limited and heterogeneous and fails to meet the needs of public health emergency preparedness and response.…”

Section: Dynamic Trends Of the Covid-19 Pandemicmentioning

confidence: 99%

“…55 Recently, the WHO Classification and Terminology Unit, proposed updates in the ICD-10 56 and ICD-11 57 COVID-19 related situations classification and coding. 7 Even with 48.5% of the survey participants not being aware of these updates, it is expected that overall awareness may increase due to the urgent need of using these international standards in the outbreak situation.…”

Section: Lessons From the Fieldmentioning

confidence: 99%

See 2 more Smart Citations

Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic

Tanno¹,

Demoly²,

Martin³

et al. 2021

World Allergy Organization Journal

Self Cite

View full text Add to dashboard Cite

Background:The COVID-19 outbreak brought an unprecedented challenge to the world. Knowledge in the field has been increasing exponentially and the main allergy societies have produced guidance documents for better management of allergic patients during this period. However, few publications so far have provided real-life data from the allergy community concerning allergy practice during the COVID-19 outbreak. Therefore, we proposed an international survey on the management of allergic patients during the current pandemic. Methods:We performed an online survey undertaken to reach out the worldwide allergy community by e-mail and social media. The web-based questionnaire contained 24 questions covering demographic data from the participants, clinical practice during this period, and questions related to the new international classification and coding tools addressed for COVID-19. It was circulated for 8 weeks and had anonymous and volunteer context.Results: Data are presented for 635 participants from 78 countries of all continents. Allergists with long-term professional experience were the main audience. As expected, we received many responses as "I have no data" or "I don't know" to the questions of the survey. However, most with more experience on managing allergic patients during the pandemic agreed that patients suffering from allergic or hypersensitivity conditions have no increased risk of contracting COVID-19 or developing SARS CoV-2. Also, participants mentioned that none of the allergy treatments (inhaled corticosteroids, allergen immunotherapy, biological agents) increased the risk of contracting COVID-19 infection including severe presentations. Conclusion:The data presented are a starting point in the process of getting feedback on all the recommendations provided by the allergy societies; it could also be the basis of new strategies to support health professionals while new COVID-19 specific treatments and vaccines are being explored. The information here presented intends to be helpful to the community but represents a

show abstract

Section: Dynamic Trends Of the Covid-19 Pandemicmentioning

confidence: 99%

Section: Dynamic Trends Of the Covid-19 Pandemicmentioning

confidence: 99%

Section: Lessons From the Fieldmentioning

confidence: 99%

See 1 more Smart Citation

Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic

Tanno¹,

Demoly²,

Martin³

et al. 2021

World Allergy Organization Journal

Self Cite

View full text Add to dashboard Cite

show abstract

“…This condition is caused by Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). SARS-CoV-2 affects different individuals in multiple ways; it commonly represents pulmonary symptoms, such as fever, dry cough, sore throat, aches and pains, headache, as well as fatigue [1]. However, extra-pulmonary symptoms caused by COVID-19 attracted much attention.…”

Section: Letter To Editormentioning

confidence: 99%

The Prevalence of Hyperamylasemia and Its Relationship With Mortality in COVID-19 Patients

Amirghofran

Ziaei

Yaghoubi

et al. 2021

IJMTFM

View full text Add to dashboard Cite

show abstract

“…The novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a global health emergency these days. Currently, more than 17.5 million confirmed cases have been reported worldwide [ 1 ]. Although COVID-19 is presenting predominantly with pulmonary manifestations, there have been many reports of multiorgan involvement, including the cardiovascular system [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report

et al. 2021

View full text Add to dashboard Cite

Background There are limited data on cardiovascular complications of coronavirus disease 2019 in pregnancy, and there are only a few case reports on coronavirus disease 2019 related cardiomyopathy in pregnancy. Differentiation between postpartum cardiomyopathy and coronavirus disease 2019 related cardiomyopathy in pregnant women who develop severe acute respiratory syndrome coronavirus-2 infection during peripartum could be challenging. Here, we present a case of possible coronavirus disease 2019 related cardiomyopathy in a pregnant patient, followed by a discussion of potential differential diagnosis. Case presentation In this case report, we present the case of a young pregnant Iranian woman who developed heart failure with pulmonary edema after cesarean section. She was treated because of low left ventricular ejection fraction and impression of postpartum cardiomyopathy, and her severe dyspnea improved by intravenous furosemide. On day 3, she exhibited no orthopnea or leg edema, but she was complaining of severe and dry cough. Further evaluation showed severe acute respiratory syndrome coronavirus-2 infection. Conclusions The possibility of severe acute respiratory syndrome coronavirus-2 infection should be considered in any pregnant woman who develops cardiomyopathy and pulmonary edema.

show abstract

Coronavirus Disease (COVID)-19: World Health Organization Definitions and Coding to Support the Allergy Community and Health Professionals

Cited by 21 publications

References 9 publications

Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic

Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic

The Prevalence of Hyperamylasemia and Its Relationship With Mortality in COVID-19 Patients

Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report

Contact Info

Product

Resources

About